Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

http://www.wikidata.org/entity/Q54611731

about

The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition Expression of ACE and ACE2 in patients with hypertensive nephrosclerosis.Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase.ACE and ACE2 in kidney disease Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system Angiotensin-converting enzyme 2: the first decade.A Genetic Variant in the Distal Enhancer Region of the Human Renin Gene Affects Renin Expression.Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury Determinants of plasma renin activity: role of a human renin gene variant as a genetic factor.Angiotensin-converting enzyme 2 and the kidney.Angiotensin converting enzyme 2 in the kidney.The sweeter side of ACE2: physiological evidence for a role in diabetes.On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.Genetic variant of the Renin-Angiotensin system and diabetes influences blood pressure response to Angiotensin receptor blockers.Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease.Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy.Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

P2860

Q24633556-96FBAA96-2080-4EDD-96FB-3D201C111D94 Q26769678-284F007E-F395-40A8-A102-C81B7E88312F Q28577739-654D0B6B-FD2D-4315-9C0F-52422AF2994F Q33827868-7E5A0C68-3DCA-4A22-9547-88F834242F9E Q34023084-A2EDF121-0CF0-40B6-8C48-915A04B4B1BA Q35050821-6FB5340D-22CF-42C2-99E9-306210338B75 Q35230775-83805B95-0D30-4539-B827-8420A14B9E33 Q35550937-C8F9C4CB-1644-4DFC-8030-D082DEDEE0AA Q35772263-DC5E2067-524C-49D1-8EE8-4146991F2CE5 Q35916066-0FDD4F17-145F-4089-9126-B3349F596DF9 Q36151790-25013055-19CD-437F-BF80-DF915E6B7A9F Q37068454-C4603BA2-2AF6-42D7-89C4-566494C5EC63 Q37097117-2C5C5CAA-9E40-4803-944D-B16D4EC428F1 Q37178255-691CEDAC-9CA0-4D1A-9F13-62C926008084 Q37260954-6E787ABE-7D97-4C55-8E88-82CA38BEDE17 Q37269523-8749D723-D7A4-43EB-B3F3-FDA99DCEA27D Q37375567-DA941BC6-22AD-44B4-999D-1742480FF101 Q37827620-9204F4E1-4CF5-4C24-969C-FF79FA3B5635 Q38787036-10231216-BE2C-4782-A67A-B1B644C22A97 Q40134736-C01304D9-92FF-4319-9CCF-B52CED7F30D5 Q42710874-5816FF39-8AE2-4E74-AC56-2310D9806AA3 Q47135346-4C5417C6-65F4-4047-87D0-3D29FCD4EBA0 Q55465043-2EFA9B1A-C0A2-41AC-BB4F-F3CC5268C441

P2860

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

http://www.wikidata.org/entity/Q54611731

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@en

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@nl

type

label

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@en

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@nl

prefLabel

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@en

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@nl

P1433

Q54611731-E5797C01-35BB-49DB-9C08-B9C3186E44C6

P1476

Q54611731-AE7608DC-8242-4EA3-AB53-16E519ECF65F

P2093

Q54611731-0A3B04BE-9BF2-4D81-9C22-A347D5CE5600

Q54611731-1742008A-3D9B-47AC-BB3B-BB0049002481

Q54611731-22202428-9A38-49B8-990C-FDD2DEA80209

Q54611731-3857BCF5-1925-4AFD-AEFC-0D17A154BF79

Q54611731-4E2CFC5E-6654-4422-8905-4E4C0461D759

Q54611731-773360E1-44B4-4BFC-9898-CF8DF4CD464D

Q54611731-78E06ECC-9054-4677-B38D-774DDC038B05

Q54611731-88545FBA-9239-465E-B27C-1530855478B0

Q54611731-B52CB42E-C386-4E40-8D15-450591D4266B

Q54611731-B7B59B26-1A3A-4E87-A565-9B86DBD4002F

P304

Q54611731-68AB079F-9C83-4A31-8238-902AB0376067

P31

Q54611731-159F24E6-89BE-4275-B251-DC46B4BAE3F6

P356

Q54611731-34D92C58-440C-4057-BAFA-C1003745BD4B

P407

Q54611731-94973142-4A41-4DB4-83DD-CD3E15EAE75F

P433

Q54611731-80944B7D-2613-44AD-A9E3-4C864C000C18

P478

Q54611731-EDFC3D61-1CC9-4BE2-9593-CD38CA6BEB31

P577

Q54611731-1403EC43-B739-41FC-8464-1A1A533E0C0D

P5875

Q54611731-FAF5A115-8353-4DA5-AFEA-7E176F50297F

P698

Q54611731-B0E66F52-D680-473A-B23E-0B1F919FCE3D

P356

DIACARE.29.04.06.DC05-1873

P1433

P1476

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

@en

P2093

Chikako Aoyama

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mabuchi

http://www.w3.org/2001/XMLSchema#string

Ichiro Koni

http://www.w3.org/2001/XMLSchema#string

Isamu Miyamori

http://www.w3.org/2001/XMLSchema#string

Makoto Motomura

http://www.w3.org/2001/XMLSchema#string

Norihiro Kato

http://www.w3.org/2001/XMLSchema#string

Shigeyuki Wakahara

http://www.w3.org/2001/XMLSchema#string

Shinichi Mizuno

http://www.w3.org/2001/XMLSchema#string

Tadashi Konoshita

http://www.w3.org/2001/XMLSchema#string

Yasukazu Makino

http://www.w3.org/2001/XMLSchema#string

P304

848-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACARE.29.04.06.DC05-1873

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7211142

http://www.w3.org/2001/XMLSchema#string

P698

16567826

http://www.w3.org/2001/XMLSchema#string